The Global Drug Delivery Infusion System Market is expected to grow at a CAGR of 14.3% during the forecasting period (2023-2030). Drug Delivery Infusion Systems are used to administer medications and fluids to critically ill patients by infusion. The global Drug Delivery Infusion Systems market was estimated at USD 9 billion in 2017. The market is driven by the increased prevalence of chronic diseases such as cancer and diabetes coupled with rising demand for improved patient care. As a result, the market will witness increased usage across different therapeutic indications over the forecast period. However, factors concerning patient safety and improper infusion leading to severe consequences will hamper the growth of the market.
Metrics |
Details |
Market CAGR |
5.8% |
Segments Covered |
By Type, By Application, By End User, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
The global Drug Delivery Infusion Systems market report segments the market by product type, by application, by the end-user, and by region. Based on product, the market is segmented into volume pumps, enteral pumps, syringe pumps, insulin pumps, ambulatory pumps, implantable pumps. Volumetric pumps were the major contributor to the market in 2017. Based on what these devices are being used and in which therapeutic area, the market is segmented into diabetes, oncology, analgesia, nutrition, hematology, and pediatrics.
Regionally, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW. North America accounted for the largest market share in the global Drug Delivery Infusion Systems market in 2017 owing to positive government regulations and reimbursement policies.
Asia Pacific region recorded the highest growth rate because of rising healthcare expenditure and increasing patient awareness. The report also profiles the following companies in the Drug Delivery Infusion Systems market – Acromed AG, B. Braun Melsungen AG, Baxter International, Becton Dickinson and Company, Caesarea Medical Electronics Ltd., Flowonix Medical Inc., Fresenius Kabi, IRADIMED CORPORATION, Medtronic, Terumo Corporation, ICU Medical, Inc. and Insulet Corporation.
By Product Type
Volumetric pumps
Syringe Infusion Systems
Ambulatory Infusion Systems
Implantable Infusion Systems
Insulin Infusion pumps
Enteral Infusion Systems
By Application
Oncology/Chemotherapy
Diabetes
Analgesia
Nutrition
Haematology
Paediatrics
By End-User
Hospital
Ambulatory Surgical Centre
Home care setting
By Region
Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
North America (The USA, Canada, Mexico)
South America (Brazil, Argentina, Rest of South America)
Rest of the World
$4350
$4350
$4350
$4350
$4350
$4350